Breaking News on Pharmaceutical Technology

Reimportation is “legislative madness”

19-Nov-2009 - It is “legislative madness” to allow reimportation in the US, according to the chair of EAASM who spoke at AAPS about Europe’s “porous supply chain” and how it could affect the standard of medicines in the States.

News in brief

UCB to cut 200 jobs in UK and Belgium

19-Nov-2009 - Belgian biotech UCB is to reduce workforce 2 per cent as part of R&D restructuring plan according to various reports.

People on the move: pharma jobs

19-Nov-2009 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Xoma and Watson Pharmaceuticals, plus a new role for Fred Hasaan.

Failed anti-depressant flibanserin reborn as female “Viagra”?

18-Nov-2009 - Boehringer Ingelheim looks set for a significant windfall with results from Phase III trials indicating that its drug flibanserin can boost sexual desire in women, raising the prospect of a female equivalent to Pfizer’s Viagra.

Emergent buys Baltimore production plant

17-Nov-2009 - US biotech Emergent BioSolutions has bought a manufacturing facility from Maryland’s MdBio Foundation is a bid to expand its production infrastructure.

News in brief

GSK teams up with Nabi on NicVax

17-Nov-2009 - GSK has signed a $540m (€362m) licensing agreement with Nabi Biopharmaceuticals for the Phase III candidate nicotine vaccine, NicVAX.

API quality enforcement in disarray; Villax

17-Nov-2009 - Regulatory enforcement efforts to tackle counterfeit and substandard APIs are in disarray, according to Guy Villax, CEO of Hovione, who spoke at AAPS about the scale of the problem.

AAPS - trends in turbulent times

12-Nov-2009 - AAPS 2009 has drawn to a close but over the three days numerous trends and debates emerged, including the strategies CROs are using in the downturn, and we take a look at these in our conference round up.

Six Pfizer-Wyeth R&D sites to close post merger

10-Nov-2009 - Pfizer will close six R&D facilities in the US and the UK, reducing its global capacity by over a third following completion of its acquisition of Wyeth.

AAPS - round up of day one

10-Nov-2009 - Following the first full day of AAPS 2009 in Los Angeles, California, US we take a look at the major developments and talking points.

People on the move: pharma jobs

10-Nov-2009 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Sanofi-Aventis, RXi Pharmaceuticals and Vivus.

Exclusive aggregation of all the news from AAPS 2009

09-Nov-2009 - in-PharmaTechnologist presents an exclusive widget that aggregates all the breaking news from AAPS 2009 in Los Angeles, US, including podcasts, articles and tweets from our in-house journalists at the show.

ICH makes progress on S9, S6 and Q8-10 workshops

09-Nov-2009 - The ICH says it made progress on its S9 guideline on non-clinical data requirement for late-stage cancer treatments at its most recent steering committee meeting in Missouri, US.

News in brief

New Jersey R&D sites vital, says Merck CEO

05-Nov-2009 - US R&D facilities in Rahway and Kenilworth, New Jersey will remain operational as they are vital to the to the newly formed Merck Schering-Plough group, according to CEO Richard Clark.

News in brief

GSK and Pfizer launch ViiV Healthcare

04-Nov-2009 - GSK and Pfizer have launched their HIV focused JV, ViiV Healthcare with the promise that it will undertake “relentless pursuit” of new drugs.

DNA tests required for Trovan claimants after data lost

03-Nov-2009 - Pfizer and Nigerian authorities want Trovan compensation claimants to provide DNA samples to confirm their identity, according to former Nigerian Supreme court justice Abubakar Wali.

People on the move: pharma jobs

03-Nov-2009 - in-PharmaTechnologist presents its latest roundup of movements in the pharma sector, including appointments at Intrexon, Cephalon, NeoPharma and Chelsea Therapeutics.

Influenza: statins may help, but did aspirin misuse hinder in 1918?

02-Nov-2009 - Early-stage CDC research suggests that the anti-inflammatory properties of cholesterol-busting statin drugs can help mitigate the impact of flu infection.

Efficacy at Ph III: lupus drug Benlysta confirms blockbuster potential

02-Nov-2009 - Good news for Human Genome Sciences (HGS) as development partner GSK reports Ph III data showing that their co-owned lupus treatment Benlysta (belimumab) is effective.

Work begins on Indian seasonal flu vacc plant

29-Oct-2009 - Novavax says its new Indian vaccine plant will be operational in four months with sufficient capacity to help meet local demand for seasonal influenza vaccines.

News in brief

Pfizer, GSK and Bayer accept Ecuador’s plan to break patents

29-Oct-2009 - Late last week Ecuador’s government announced plans to sidestep patents on more than 2,000 drugs, enabling them to produced local or imported as “generics”

OctoPlus, Glycotope, Merck KGaA and SCM Pharma on BioPh 2009

29-Oct-2009 - How successful was the BioPh conference in Madrid? in-PharmaTechnologist asked key players attending the inaugural event.

People on the move: pharma jobs

27-Oct-2009 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Hospira, PTI, Migenix and Shrink Nanotechnologies.

IMS Health looking at buyout bids

22-Oct-2009 - IMS Health has confirmed it is “exploring strategic alternatives” after speculation this week suggested that the market analysis group had received a number of takeover bids.